(5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
CAS: 363-24-6
Ref. IN-DA0034RV
1mg | 88,00 € | ||
10mg | 118,00 € | ||
100mg | 527,00 € | ||
250mg | 559,00 € |
- Arzneimittelwirkstoffe (API) zugehörige Verbindungen
- Arzneimittelwirkstoffe (API) für Forschungszwecke
- Biochemikalien und Reagenzien
- Krebsforschung
- Zellkulturreagenzien
- Zelluläre und molekulare Biologie
- Chirale organische Verbindungen
- Fettsäuren
- Immunologie und Inflammation
- Lipide
- Neurowissenschaften
- Pharmazeutische und veterinäre Verbindungen und Metabolite
Produktinformation
- Dinoprostone
- Gel, Prepidil
- Prepidil Gel
- Prostenon
- Dinoprostone
- Prepidil
- Cervidil
- Propess
- Dinoproston
- Prostin
- Mehr Synonyme anzeigen
- Prostarmon E
- Dinoprostonum
- Dinoprostona
- Prostaglandin E
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
- l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
- (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l-
- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-
- Prostaglandin E(2)
- (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid
- (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
- (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate
- Prepidil Gel
- (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-
- 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
- (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid
- 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid
- Cerviprime
- Prostenone
- Enzaprost E
- Prostin E
- Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo-
- (5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo-
- Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
- Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
- 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid
- [3H]dinoprostone
- 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
- prosta-glandin e2
- (E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid
- Dinoprostone beta-Cyclodextrin Clathrate
- prostaglandin-e2-cervidil
- (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic
- (5Z,11|A,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
- (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate
- (5Z,11?,13E,15S)-11,15-Dihydroxy-9-oxo-prosta-5,13-dien-1oic acid
- (5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid
- (-)-Prostaglandin E<sub>2</sub>
- (11alpha,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (15S)-Prostaglandin E2
- (15S)-Prostaglandin E<sub>2</sub>
- (5E,13E)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oate
- (5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
- 11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11α,13E,15S)
- 11α,15α-Dihydroxy-9-ketoprosta-5,13-dienoic acid
- 11α,15α-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid
- 5-Heptenoic acid, 7-[3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
- 7-[3-Hydroxy-2-(3-Hydroxy-1-Octenyl)-5-Oxo-Cyclopentyl]-5-Heptenoic Acid
- Cerviprost
- Glandin
- Minprositin E2
- Minprositin E<sub>2</sub>
- Minprostin E2
- Minprostin E<sub>2</sub>
- Nsc 165560
- Nsc 196514
- PGE<sub>2</sub>
- Pge2
- Primiprost
- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11α,13E,15S)-
- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8ξ,12ξ,13E)-
- Prosta-5,13-diene-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E15S)-
- Prostin (prostaglandin)
- Prostin E2
- Prostin E<sub>2</sub>
- U 12062
- Vivelle-Dot
- l-PGE2
- l-PGE<sub>2</sub>
- l-Prostaglandin E2
- l-Prostaglandin E<sub>2</sub>
Chemische Eigenschaften
Technische Anfrage zu: IN-DA0034RV (5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.